Progress and Controversies in Gynecologic Oncology Conference

Transcription

1 2012 Progress and Controversies in Gynecologic Oncology Conference April 2012 Hotel Fira Pa la ce Ba rcelona, Spain A prime Oncology activity.

2 Welcome On behalf of the Scientific Committee, we are pleased to invite you to the 2012 Progress and Controversies in Gynecologic Oncology Conference, to be held in Barcelona, Spain, on April This meeting will serve as a valuable forum for the presentation and discussion of newly available data across various gynecologic malignancies including ovarian, cervical, and endometrial cancers. Participants will be provided with updates on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients. Who Should Attend The 2012 Progress and Controversies in Gynecologic Oncology Conference is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners including allied health professionals, involved in the diagnosis and management of gynecologic malignancies. Learning Objectives After a successful completion of this educational activity, participants should be able to: Develop a practical approach to cervical cancer staging and disease management Discuss the role of radiotherapy and systemic therapies in the management of endometrial cancer Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation Assess standard and emerging therapeutic options for ovarian cancer and discuss their impact on patient outcomes Scientific Committee Andreas du Bois, MD, PhD Klinikum Essen Mitte Essen, Germany University of Milan Bicocca Peter G. Harper, MD, FRCP Guy s and St Thomas Hospital London, United Kingdom The Royal Marsden Hospital Sutton, United Kingdom Bradley J. Monk, MD, FACS, FACOG Creighton University School of Medicine at St Joseph s Hospital and Medical Center Phoenix, Arizona, United States Fundacion Instituto Valenciano de Oncologia Valencia, Spain Centre Hospitalier Universitaire Hotel-Dieu Paris, France University Hospital Gasthuisberg Leuven, European Union Continuing Education The Accreditation Council on Oncology in Europe (ACOE) is a multidisciplinary body of full time specialists practising in the field of oncology and all recognised for their experience in education and expertise in their field. ACOE acknowledges the quality of the scientific programme and its educational value. The ACOE accreditation label provides delegates with a guarantee of a high quality and unbiased educational activity. ACOE accredited events are awarded an agreed number of CME credit points (1 CME credit per educational hour), with a maximum of 6 credits per day. ACOE works in conjunction with the European Accreditation Council for Continuing Medical Education (EACCME ) operating under the umbrella of the European Union of Medical Specialists (UEMS). EACCME acts as a clearinghouse, facilitating the accreditation endorsement by the national CME regulatory bodies Progress and Controversies in Gynecologic Oncology Conference is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), Progress and Controversies in Gynecologic Oncology Conference has been designated a maximum of 9 hours of European CME credits (ECMECs). The Congress operates an honour system implying that each medical specialist is expected to claim only those hours of credit that he/she actually spent at the Congress (with a maximum of 6 credits per day, 3 for a half day). CME credits gained through participation at 2012 Progress and Controversies in Gynecologic Oncology Conference are recognised by most of the national CME authorities in Europe, which have agreed to cooperate in this European system. More information on the recognition of European credits in the European Countries, please refer to the ACOE website: (select CME credits recognition ).Through a mutual agreement between the UEMS and the American Medical Association (AMA), the European CME credits are also recognised towards the Physician s Recognition Award (PRA). To convert European CME credits to AMA PRA Category 1 Credits TM please contact AMA at: Faculty Giovanni Aletti, MD European Institute of Oncology Antonio González Martín, MD M. D. Anderson Cancer Center Madrid, Spain Philipp Harter, MD Klinikum Essen Mitte Essen, Germany Christhardt Köhler, MD Charité University Hospital Berlin, Germany Sean Kehoe, MD, FRCOG Oxford Radcliffe Hospital Oxford, United Kingdom Angelo Maggioni, MD European Institute of Oncology Christian Marth, MD Innsbruck University Hospital Innsbruck, Austria Sandro Pignata, MD, PhD National Cancer Institute Naples, Italy Jaime Prat, MD, FRCPath Hospital de la Santa Creu i Sant Pau Barcelona, Spain Isabelle Ray-Coquard, MD, PhD Centre Léon Bérard Lyon, France Gillian Thomas, MD Sunnybrook Odette Cancer Center Toronto, Ontario, Canada Ate G.J. van der Zee, MD, PhD University Medical Center Groningen Groningen, the Netherlands

3 2012 Progress and Controversies in Gynecologic Oncology Conference April 2012 / Hotel Fira Palace / Barcelona, Spain Friday, 13 April Welcome reception Introduction Session I Cervical Cancer and Vulvar Cancer Moderators: Interactive Clinical Case: Locally advanced cervical cancer Antonio González Martín, MD Expert Opinion/Debate: Is there a role for surgical staging in operable cervical cancer? Pro surgical staging: Christhardt Köhler, MD Con surgical staging: Gillian Thomas, MD Update on cytotoxic and targeted therapies for cervical cancer Bradley J. Monk, MD, FACS, FACOG Updates in the treatment of vulvar cancer Ate G.J. van der Zee, MD, PhD Break Session II Endometrial Cancer and Beyond Moderators: Andreas du Bois, MD, PhD What is the role of robotic surgery in gynecologic cancer? Angelo Maggioni, MD Expert Opinion/Debate: There are still indications for lymphadenectomy in endometrial cancer Pro: Giovanni Aletti, MD Contra: Sean Kehoe, MD, FRCOG Interactive Clinical Case: Stage IB grade 3 endometrioid endometrial cancer Update on advanced/recurrent uterine neoplasm management: Considering new agents Concluding remarks: Day Adjourn Saturday, 14 April Introduction Session III Ovarian Neoplasm I: First-Line Therapy Moderators: 8.50 New concepts in the biology of ovarian cancer Jaime Prat, MD, FRCPath 9.20 The role of radical surgery in advanced ovarian cancer Andreas du Bois, MD, PhD 9.50 Interactive Clinical Case: First-line therapy for advanced ovarian cancer Sandro Pignata, MD, PhD Break Session IV Ovarian Neoplasm II: Emerging Novel Therapies Moderators: Bradley J. Monk, MD, FACS, FACOG Antiangiogenesis Isabelle Ray-Coquard, MD, PhD Beyond antiangiogenesis Lunch symposium Session V Ovarian Neoplasm II: Recurrence Moderators: Peter G. Harper, MD, FRCP Surgery for recurrent ovarian cancer Philipp Harter, MD Interactive Clinical Case: Platinum-resistant disease Christian Marth, MD Interactive Clinical Case: Relapse at 6-12 months Interactive Clinical Case: Platinum-sensitive disease Brief reports on hot topics in ovarian cancer: 1) Low-grade serous carcinomas 2) Clear cell carcinomas Peter G. Harper, MD, FRCP 3) Mucinous carcinomas Concluding remarks Adjourn

4 Venue Hotel Fira Palace Avenida Rius i Taulet, 1-3 Barcelona, Spain Registration Fees for activity and registration Physician early registration: 250 Physician regular registration: 350 Physician onsite registration: 450 Nurses / Fellows early registration: 100* Nurses / Fellows regular registration: 150* Nurses / Fellows onsite registration: 200* Registration fees include VAT *Supporting documentation of eligibility may be required. Registration deadlines Early registration rate: 5 March 2012 Regular registration rate: 9 April 2012 To register You may register online by 9 April 2012 at gyncongress2012. Registration confirmations will be issued upon successful registration and reminders will be issued before the meeting. To preregister, registration and payment must be received no later than 5 March 2012 (early registration rate) or 9 April 2012 (regular registration rate). Please register onsite after 9 April Group registrations Group registration will be accepted. Further information will be available upon inquiry at gyncongress2012@primeoncology.org For groups different payment and cancellation policy applies. Please check the conference Website for full information. Cancellation To receive a refund of registration fees, written notice of cancellation must be received at gyncongress2012@primeoncology.org. The following deadlines and cancellation fees will apply: Before 10 March 2012, a 75 administrative charge From 10 March 2012, a 50% cancellation fee applies on registration fee(s) From 1 April 2012, a 100% cancellation fee applies on registration fee(s) The amount of registration fees remitted will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 31 March prime Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice. Register Online at: REGISTRANT INFORMATION REGISTRATION First Name Last Name Degree Institution Address Phone Number Street Address City Country Postal Code REGISTRATION FEES EARLY REGISTRATION (by 5 March 2012) REGULAR REGISTRATION Physician: Physician: Nurses/Fellows: Nurses/Fellows: (Proof of eligibility is required for reduced fee) (Proof of eligibility is required for reduced fee) Other: Other: Registration fees include VAT Promotional Code: CANCELLATION POLICY To receive a refund of registration fees, written notice of cancellation must be received at gyncongress2012@primeoncology.org. The following deadlines and cancellation fees will apply: * Before 10 March 2012, a 75 administrative charge * From 10 March 2012, a 50% cancellation fee applies on registration fee(s) * From 1 April 2012, a 100% cancellation fee applies on registration fee(s) The amount of registration fees remitted will be refunded after the Conference. Substitutions are accepted with written notification. No refunds for notices received after 31 March prime Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrant Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice. ACCOMMODATIONS HOTEL FIRA PALACE Avenida Rius i Taulet, 1-3, Barcelona, I will require accommodations I will NOT require accommodations RATES (including breakfast and VAT): Standard booking fee from 1 January 2012 Double room for single occupancy 175 Double standard room 190 If you selected that you require accommodations, please fill in the following: Thursday, 12 April 2012 Friday, 13 April 2012 Saturday, 14 April 2012 Room Preference: Smoking Room Non-Smoking Room A cancellation fee may apply in the event the delegate will cancel his/her (registration and) hotel accommodation. A written notice of cancellation must be received at gyncongress2012@primeoncology.org. - From 5 March 2012 the cancellation fee will be 50% of the room rate of the entire stay - From 22 March 2012 the cancellation fee will be 100% of the room rate of the entire stay The amount of hotel room fees remitted will be refunded after the Conference. Substitutions accepted with written notification. In case of no-shows a 100% cancellation fee of the entire stay will apply. CREDIT CARD INFORMATION Credit Card number is required for registration. CREDIT CARD TYPE: Visa MasterCard American Express CREDIT CARD NUMBER: EXP DATE: CVC Code (three digit code on back of Visa/MasterCard, four digit code on front of AMEX): BILLING ADDRESS (if different from above): SIGNATURE OF CARDHOLDER: I authorize prime Oncology to charge my credit card for the total of amounts checked above. CARDHOLDERS NAME (please print): Fax to: or to: gyncongress2012@primeoncology.org

5 13-14 April 2012 / Hotel Fira Palace / Barcelona, Spain Support for this educational activity is provided by: FOUNDING SILVER Grupo Zelti EXHIBITOROR About prime Oncology EU Office prime Oncology Scheveningseweg KW The Hague the Netherlands prime Oncology is a global professional Independent Medical Education organization specializing in educational activities for physicians who treat patients with cancer. With the ultimate goal of improving patient outcomes, prime Oncology provides evidence-based, state-of-the-art educational activities that assist oncology clinicians in making up-to-date and appropriate treatment decisions.